Susan D Housholder-Hughes1, Melanie M Martin2, Marilyn R McFarland3, Constance J Creech3, Michael J Shea4. 1. Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: shoushol@umich.edu. 2. Dickinson Cardiology Services, Dickinson County Healthcare System, Iron Mountain, MI, USA. 3. Nursing Department, School of Health Professionals and Studies, University of Michigan-Flint, Flint, MI, USA. 4. Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Atherosclerotic cardiovascular disease is the foremost cause of death for U.S. adults. The 2013 ACC/AHA Adult Cholesterol Guidelines recommend high-intensity dose statins for individuals with coronary artery disease (CAD). OBJECTIVE: To determine healthcare provider compliance with the Cholesterol Guideline recommendation specific to high-intensity dose statins for patients with CAD. METHODS: A retrospective chart review was conducted to determine compliance rate. A questionnaire was developed to evaluate healthcare provider beliefs, attitudes, and self-confidence toward this recommendation. RESULTS: Of the 473 patients with CAD, 67% were prescribed a high-intensity dose statin. Patients with non-ST segment myocardial infarction and ST segment myocardial infarction were more likely to be prescribed a high-intensity dose statin versus a moderate or low-intensity dose. Healthcare providers strongly agreed with this guideline recommendation. CONCLUSION: There exists a dichotomy between intention to prescribe and actual prescribing behaviors of high-intensity dose statin for patients with CAD.
BACKGROUND:Atherosclerotic cardiovascular disease is the foremost cause of death for U.S. adults. The 2013 ACC/AHA Adult Cholesterol Guidelines recommend high-intensity dose statins for individuals with coronary artery disease (CAD). OBJECTIVE: To determine healthcare provider compliance with the Cholesterol Guideline recommendation specific to high-intensity dose statins for patients with CAD. METHODS: A retrospective chart review was conducted to determine compliance rate. A questionnaire was developed to evaluate healthcare provider beliefs, attitudes, and self-confidence toward this recommendation. RESULTS: Of the 473 patients with CAD, 67% were prescribed a high-intensity dose statin. Patients with non-ST segment myocardial infarction and ST segment myocardial infarction were more likely to be prescribed a high-intensity dose statin versus a moderate or low-intensity dose. Healthcare providers strongly agreed with this guideline recommendation. CONCLUSION: There exists a dichotomy between intention to prescribe and actual prescribing behaviors of high-intensity dose statin for patients with CAD.
Authors: Timothy S Chang; Ashwin Buchipudi; Gregg C Fonarow; Michael A Pfeffer; Jennifer S Singer; Eric M Cheng Journal: Appl Clin Inform Date: 2019-06-19 Impact factor: 2.342